top of page
9 juil. 2020
Theranexus reported €13.3 M pro forma cash at 30 June 2020 and set up a flexible €4.2 M mandatory convertible bond facility with IRIS to support its growth, notably the BBDF-101 program.
Lyon, France, 9 July 2020 - Theranexus strengthened its financial visibility with €13.3 M pro forma cash at mid-2020 and the launch of a €4.2 M mandatory convertible bond line structured in 12 tranches over 12 months. This financing, fully at the company’s discretion for drawdowns, is intended to fund upcoming development steps, particularly for BBDF-101, while providing at least 18 months of operational runway.
Download Theranexus press release
bottom of page